Supernus Pharmaceuticals (SUPN) Q1 2021 Earnings

25FebConfirmed
Q2 2020
Aug 20
Q4 2020
Q1 2021
0.27
0.43
0.58
0.74

Details

Expected EPS
0.59
Actual EPS
0.57
Surprise EPS
-0.02
Surprise Percent
+3.39%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.57 per share for Q1 2021.

0 Comments

Share your thoughts